Early evidence that CYCLIN D and CDK4/6 activities are upregulated in certain tumor cell types, and that cdk4-/- mice fail to develop MMTV-neu and MMTV-ras-induced mammary tumors, led to concerted efforts to develop small molecule inhibitors for these kinases. This evidence concerns the gene CDK4 and breast cancer.